Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Inventory (2021 - 2025)

InMed Pharmaceuticals' Inventory history spans 5 years, with the latest figure at $947898.0 for Q4 2025.

  • For Q4 2025, Inventory fell 14.09% year-over-year to $947898.0; the TTM value through Dec 2025 reached $947898.0, down 14.09%, while the annual FY2025 figure was $961173.0, 22.76% down from the prior year.
  • Inventory reached $947898.0 in Q4 2025 per INM's latest filing, up from $890807.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $2.5 million in Q2 2022 to a low of $744839.0 in Q4 2023.
  • Average Inventory over 5 years is $1.3 million, with a median of $1.2 million recorded in 2024.
  • Peak YoY movement for Inventory: skyrocketed 63.17% in 2022, then plummeted 53.84% in 2023.
  • A 5-year view of Inventory shows it stood at $988822.0 in 2021, then surged by 63.17% to $1.6 million in 2022, then tumbled by 53.84% to $744839.0 in 2023, then soared by 48.13% to $1.1 million in 2024, then dropped by 14.09% to $947898.0 in 2025.
  • Per Business Quant, the three most recent readings for INM's Inventory are $947898.0 (Q4 2025), $890807.0 (Q3 2025), and $961173.0 (Q2 2025).